Company Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.
The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.
It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards.
The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Country | United States |
Founded | 1996 |
Industry | Pharmaceutical Retailers |
Sector | Healthcare |
Employees | 287 |
CEO | Sandra Campos |
Contact Details
Address: 420 South Congress Avenue Delray Beach, Florida 33445 United States | |
Phone | 561 526 4444 |
Website | 1800petmeds.com |
Stock Details
Ticker Symbol | PETS |
Exchange | NASDAQ |
Fiscal Year | April - March |
Reporting Currency | USD |
CIK Code | 0001040130 |
CUSIP Number | 716382106 |
ISIN Number | US7163821066 |
Employer ID | 65-0680967 |
SIC Code | 5912 |
Key Executives
Name | Position |
---|---|
Sandra Y. Campos | President, Chief Executive Officer and Director |
Christine Chambers | Treasurer and Secretary |
Robyn DElia | Chief Financial Officer |
Caroline Conegliano | Chief Operating Officer |
Doug Krulik | Chief Accounting Officer |
Mark Moseley | Chief Technology and Information Officer |
Carla Dodds | Chief Marketing Officer |
Jacqueline Smith | Vice President of People |
Umesh Sripad | Chief Digital and Technology Officer |
Wendy Zalai | Corporate Controller and Corporate Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 7, 2024 | 10-Q | Quarterly Report |
Nov 6, 2024 | 8-K | Current Report |
Oct 10, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Sep 27, 2024 | 8-K | Current Report |
Sep 27, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
Sep 12, 2024 | 8-K | Current Report |
Aug 8, 2024 | 8-K | Current Report |
Aug 8, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
Aug 7, 2024 | 10-Q | Quarterly Report |